Center Trials & Treatment Inc. Report issue

For profit Phase 1
Founded: Bloomingburg NY United States (2017)

Organization Overview

First Clinical Trial
2018
NCT03426254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Center Trials & Treatment | Center Trials & Treatment Europe | Center Trials & Treatment Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Astrocytoma (Phase 1)

Breast Neoplasms (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Glioblastoma (Phase 1)

Glioma (Phase 1)

Gliosarcoma (Phase 1)

Lung Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 6
  • # of Trial APIs: 8